Serum bile acid profiles are associated with heart failure with preserved ejection fraction in patients with metabolic dysfunction‐associated fatty liver disease: An exploratory study

Documenti analoghi

• Associations between cuprotosis‐related genes and the spectrum of metabolic dysfunction‐associated fatty liver disease: An exploratory study
  di: Hai‐Yang Yuan, et al.
  Pubblicazione: (2024)
• Causal relationship between key genes and metabolic dysfunction‐associated fatty liver disease risk mediated by immune cells: A Mendelian randomization and mediation analysis
  di: Gong Feng, et al.
  Pubblicazione: (2024)
• Hepatic thyroid hormone receptor‐β signalling: Mechanisms and recent advancements in the treatment of metabolic dysfunction‐associated steatohepatitis
  di: Stergios A. Polyzos, et al.
  Pubblicazione: (2024)
• Is the combination of resmetirom and semaglutide useful for the treatment of metabolic dysfunction‐associated steatohepatitis?
  di: Stergios A. Polyzos, et al.
  Pubblicazione: (2026)
• High‐intensity interval training induces lactate dehydrogenase B lactylation to inhibit hepatic lipogenesis to alleviate metabolic dysfunction‐associated fatty liver disease
  di: Wenhua Huang, et al.
  Pubblicazione: (2026)